journal article Jun 15, 2023

Association of choline and betaine with the risk of cardiovascular disease and all‐cause mortality: Meta‐analysis

View at Publisher Save 10.1111/eci.14041
Abstract
AbstractBackgroundThis study aimed to systematically evaluate the role of circulating levels of choline and betaine in the risk of cardiovascular disease (CVD) and all‐cause mortality by comprehensively reviewing observational studies.MethodsThis study was conducted according to PRISMA 2020 statement. Six electronic databases, including PubMed, Embase and China National Knowledge Infrastructure (CNKI), were searched for cohort studies and derivative research design types (nested case–control and case‐cohort studies) from the date of inception to March 2022. We pooled relative risk (RR) and 95% confidence interval (CI) of the highest versus lowest category and per SD of circulating choline and betaine concentrations in relation to the risk of CVD and all‐cause mortality.ResultsIn the meta‐analysis, 17 studies with a total of 33,009 participants were included. Random‐effects model results showed that highest versus lowest quantile of circulating choline concentrations were associated with the risk of CVD (RR = 1.29, 95% CI: 1.04–1.61) and all‐cause mortality (RR = 1.62, 95% CI: 1.12–2.36). We also observed the risk of CVD were increased 13% (5%–22%) with per SD increment. Furthermore, highest versus lowest quantile of circulating betaine concentrations were not associated with the risk of CVD (RR = 1.07, 95% CI: 0.92–1.24) and all‐cause mortality (RR = 1.39, 95% CI: 0.96–2.01). However, the risk of CVD was increased 14% (5%–23%) with per SD increment.ConclusionsHigher levels of circulating choline were associated with a higher risk of CVD and all‐cause mortality.
Topics

No keywords indexed for this article. Browse by subject →

References
60
[4]
2020 Dietary guidelines advisory committee (2020)
[16]
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis

Robert A Koeth, Zeneng Wang, Bruce S Levison et al.

Nature Medicine 10.1038/nm.3145
[24]
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt et al.

BMJ 10.1136/bmj.n71
[25]
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan AC Sterne, Miguel A Hernán, Barnaby C Reeves et al.

BMJ 10.1136/bmj.i4919
[33]
Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide

Z. Wang, W. H. W. Tang, J. A. Buffa et al.

European Heart Journal 10.1093/eurheartj/ehu002
[34]
[43]
Associations of circulating choline and its related metabolites with cardiometabolic biomarkers: an international pooled analysis

Xiong-Fei Pan, Jae Jeong Yang, Xiao-Ou Shu et al.

The American Journal of Clinical Nutrition 10.1093/ajcn/nqab152

Showing 50 of 60 references